Teva Pharmaceutical Industries Limited (TEVA) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in Israel, listed on NYSE. Market cap 45.78B USD. 52-week range 18.83 to 40.79 USD. Trailing P/E 65.4. Data as of 2026-10-09.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products ...